These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6463864)

  • 61. Tumor-associated and embryonic antigens in soluble fractions of a chemically-induced rat colon carcinoma.
    Steele G; Sjögren HO; Price MR
    Int J Cancer; 1975 Jul; 16(1):33-51. PubMed ID: 1176194
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Administration of antigen by intralymphatic route in the rat. II. Results in tumor active immunotherapy (delta). Preliminary report.
    Sulis E; Busilacchi M; Turno R; Monni A; Chessa A; Zizi P; Pani P; Manconi PE
    Boll Ist Sieroter Milan; 1976 Jul; 55(3):252-4. PubMed ID: 189786
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Study of indirect active immunotherapy of Ehrlich carcinoma].
    De Santana CF; Da Silva IN
    Rev Inst Antibiot (Recife); 1974 Dec; 14(1-2):3-8. PubMed ID: 4471334
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The combined effect against colon-26 cells of heat treatment and immunization with heat treated colon-26 tumour cell extract.
    Okamoto M; Tazawa K; Kawagoshi T; Maeda M; Honda T; Sakamoto T; Tsukada K
    Int J Hyperthermia; 2000; 16(3):263-73. PubMed ID: 10830588
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Vaccination with genetically modified IL-2 secreting cells in a rat model of colonic carcinoma].
    Patry Y; Meflah K; Le Pendu J
    Bull Cancer; 1996 Mar; 83(3):218-26. PubMed ID: 8695924
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Induced adenocarcinoma of the ascending colon on LE and Wistar/Shhi rats and virus like particles in the serum of colon cancer carrying WF rats.
    Miyamoto M; Saeki K; Tani Y; Amano H; Sodoh TO; Nakao H; Konishi T
    Med J Osaka Univ; 1991 Mar; 40(1-4):5-7. PubMed ID: 1369656
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Immunotherapeutic effects of tumor-specific transplantation antigens released by 1-butanol.
    Kahan BD; Pellis NR; LeGrue SJ; Tanaka T
    Cancer; 1982 Mar; 49(6):1168-73. PubMed ID: 7059942
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An interleukin 2/sodium butyrate combination as immunotherapy for rat colon cancer peritoneal carcinomatosis.
    Perrin P; Cassagnau E; Burg C; Patry Y; Vavasseur F; Harb J; Le Pendu J; Douillard JY; Galmiche JP; Bornet F
    Gastroenterology; 1994 Dec; 107(6):1697-708. PubMed ID: 7958681
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunoprophylaxis and therapy of grafted rat colonic carcinoma.
    Martin MS; Martin F; Justrabo E; Michel MF; Lagneau A
    Gut; 1977 Mar; 18(3):232-5. PubMed ID: 323119
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Active specific immunotherapy potential for the treatment of large bowel cancer.
    Kahan BD; Pellis NR; Rutzky LP; Wiseman F; Tom BH
    Cancer; 1977 Nov; 40(5 Suppl):2740-6. PubMed ID: 922711
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Modulation of macrophage-mediated toxicity to cancer cells in vitro by liposomes and endotoxins].
    Olsson NO; Jeannin JF; Martin F
    C R Seances Soc Biol Fil; 1980; 174(6):1067-71. PubMed ID: 6451267
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Carrier and adjuvant properties of liposome-borne tumor-specific antigens.
    LeGrue SJ
    Cancer Immunol Immunother; 1984; 17(2):135-41. PubMed ID: 6565518
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Active specific immunotherapy of Dukes B2 and C colorectal carcinoma: comparison of two doses of the vaccine.
    Jessup JM; McBride CM; Ames FC; Guarda L; Ota DM; Romsdahl MM; Martin RG
    Cancer Immunol Immunother; 1986; 21(3):233-9. PubMed ID: 2938738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Immunotherapy and immunoprevention with live bacteria of undifferentiated RJL rat carcinoma.
    Lupu AN; Corneci II
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):75-85. PubMed ID: 6336509
    [No Abstract]   [Full Text] [Related]  

  • 75. A new approach for the immunogenic presentation of membrane-bound human colon tumor antigens.
    Tom BH; Goodwin TJ; Sengupta J; Kahan BD; Rutzky LP
    Immunol Commun; 1982; 11(4):315-23. PubMed ID: 6757114
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spontaneous colon cancer and its spontaneous regression in highly inbred Wistar Furth rats: genetic analysis.
    Saeki K; Miyamoto M; Kitamura H
    Med J Osaka Univ; 1989 Mar; 38(1-4):13-8. PubMed ID: 2485391
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The current status of colon cancer immunology.
    Deasy JM
    Ir Med J; 1983 Sep; 76(9):393-5. PubMed ID: 6363339
    [No Abstract]   [Full Text] [Related]  

  • 78. Immunotherapy of colon cancer: prospects for developing immunogenic vaccines based on autologous serological typing.
    Oettgen HF; Old LJ
    Cancer; 1980 Mar; 45(5 Suppl):1218-22. PubMed ID: 6153566
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Active specific immunotherapy of murine colon adenocarcinoma with recombinant vaccinia/interleukin-2-infected tumor cell vaccines.
    Bash JA
    Ann N Y Acad Sci; 1993 Aug; 690():331-3. PubMed ID: 8368746
    [No Abstract]   [Full Text] [Related]  

  • 80. Liposome-facilitated enhancement of in vitro immunity to human colon cancer.
    Sengupta J; Klesius PH; Tom BH
    Immunol Invest; 1985 Feb; 14(1):7-26. PubMed ID: 3997212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.